Salivary metabolomic identification of biomarker candidates for oral melanoma and oral squamous cell carcinoma in dogs
Open Access
- 1 July 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 38 (4) , 2293-2304
Abstract
Background: Oral melanoma (OM) and oral squamous cell carcinoma (OSCC) are frequently diagnosed in dogs, presenting a challenge in distinguishing them from benign oral tumors (BN). Salivary metabolomic biomarkers offer a practical solution because of saliva's direct contact with tumors and the noninvasive nature of collection. Objective: Assess the diversity and abundance of the salivary metabolome in dogs with BN, OM, and OSCC using amine/phenol submetabolome analysis and high-performance chemical isotope labeling liquid chromatography–mass spectrometry (CIL LC-MS). Animals: Study included 11 BN, 24 OM, 10 OSCC, and 20 healthy control dogs. Methods: Case-control cross-sectional study was conducted to assess salivary submetabolic profiles in dogs with BN, OM, and OSCC and healthy dogs. Samples were labeled with 12C-dansyl chloride and analyzed using CIL LC-MS targeted to amine- and phenol-containing metabolites for amine/phenol submetabolome analysis. Results: Distinct clusters and significant differences in metabolite concentrations were observed among the oral cancer, BN, and control groups. A total of 154 and 66 metabolites showed significantly altered concentrations, particularly in OM and OSCC, respectively, when compared with BN (Padj < .05). Potential metabolic biomarkers were identified for each cancer, including decreased concentrations of seryl-arginine and sarcosine in OSCC. Moreover, high-confidence putative metabolites were identified, including an increase in tryptophyl-threonine and a decrease in 1,2-dihydroxynapthalene-6-sulfonic acid and hydroxyprolyl-hydroxyproline for OM. Conclusions and Clinical Importance: We identified high coverage of the amine/phenol submetabolome, including seryl-arginine, and sarcosine, in OSCC. Our findings emphasize the potential of these biomarkers for distinguishing between oral OSCC and BN in dogs.Keywords
Funding Information
- an Overseas Research Experience Scholarship for Graduate Student
- Canada Foundation for Innovation
- the 100th Anniversary of Chulalongkorn University for a Doctoral Scholarship
- Genome Canada
- TRF Research Career Development Grant (RSA5980053)
- the Natural Sciences and Engineering Research Council of Canada
- the 90th Anniversary of Chulalongkorn University Scholarship
- Canada Foundation for Innovation
- Genome Canada
- Natural Sciences and Engineering Research Council of Canada
This publication has 68 references indexed in Scilit:
- Circ_0006006 facilitates non‐small cell lung cancer progression by modulating miR‐924/SRSF7 axisThe Journal of Gene Medicine, 2022
- Metabolome of canine and human saliva: a non-targeted metabolomics studyMetabolomics, 2020
- Spontaneously occurring melanoma in animals and their relevance to human melanomaThe Journal of Pathology, 2020
- Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data AnalysisCurrent Protocols in Bioinformatics, 2019
- Mass Accuracy Check Using Common Background Peaks for Improving Metabolome Data Quality in Chemical Isotope Labeling LC-MSJournal of the American Society for Mass Spectrometry, 2019
- Chemical Isotope Labeling LC-MS for Human Blood Metabolome Analysis2018
- Deletion of serine/arginine‐rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in miceHepatology, 2014
- Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profilesMetabolomics, 2012
- Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profilesMetabolomics, 2009
- Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNAChemico-Biological Interactions, 2006